Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 6.90%12.94B | ---- | 12.29%12.1B | ---- | 14.85%10.78B | ---- | 13.84%9.39B | ---- | 13.18%8.24B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -10.55%-329.38M | ---- | 7.05%-297.96M | ---- | 13.26%-320.56M | ---- | 7.59%-369.55M | ---- | 9.94%-399.9M |
| Dividend (income)- adjustment | ---- | 44.63%-11.88M | ---- | -197.02%-21.45M | ---- | 93.41%-7.22M | ---- | -209.59%-109.55M | ---- | -13.58%-35.38M |
| Attributable subsidiary (profit) loss | ---- | 4.16%-905.26M | ---- | -55.06%-944.51M | ---- | 47.13%-609.13M | ---- | 55.37%-1.15B | ---- | -88.05%-2.58B |
| Impairment and provisions: | ---- | -89.43%24.77M | ---- | 521.76%234.38M | ---- | 714.86%37.7M | ---- | ---6.13M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -79.27%19.29M | ---- | 146.83%93.05M | ---- | 714.86%37.7M | ---- | ---6.13M | ---- | ---- |
| -Other impairments and provisions | ---- | -96.12%5.48M | ---- | --141.34M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | 137.32%159.34M | ---- | 44.84%-426.92M | ---- | -58.70%-774.01M | ---- | -361.79%-487.72M | ---- | --186.3M |
| -Fair value of investment properties (increase) | ---- | 137.32%159.34M | ---- | 44.84%-426.92M | ---- | -58.70%-774.01M | ---- | -361.79%-487.72M | ---- | --186.3M |
| Asset sale loss (gain): | ---- | -286.68%-90.92M | ---- | 92.54%-23.51M | ---- | -665.91%-315.17M | ---- | 92.85%-41.15M | ---- | -2,700.49%-575.28M |
| -Loss (gain) from sale of subsidiary company | ---- | -105.48%-68.1M | ---- | 72.15%-33.14M | ---- | -352.10%-119.01M | ---- | ---26.32M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -316.47%-21.83M | ---- | -3.35%-5.24M | ---- | 65.80%-5.07M | ---- | -182.85%-14.83M | ---- | 42.64%-5.24M |
| -Loss (gain) from selling other assets | ---- | -106.67%-992K | ---- | 107.78%14.87M | ---- | ---191.1M | ---- | ---- | ---- | -4,898.55%-570.04M |
| Depreciation and amortization: | ---- | 12.18%957.71M | ---- | 24.14%853.71M | ---- | 1.57%687.69M | ---- | 62.94%677.07M | ---- | -13.60%415.52M |
| -Amortization of intangible assets | ---- | -2.16%175.24M | ---- | -3.69%179.1M | ---- | -3.63%185.96M | ---- | -11.69%192.95M | ---- | -24.05%218.48M |
| Financial expense | ---- | 0.56%3.22B | ---- | 7.12%3.2B | ---- | 12.11%2.99B | ---- | -0.44%2.67B | ---- | 17.60%2.68B |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | -99.97%31K | ---- | -23.66%123.13M | ---- | 256.38%161.28M |
| Special items | ---- | 12.59%7.4M | ---- | -80.75%6.57M | ---- | -23.38%34.13M | ---- | 120.95%44.54M | ---- | --20.16M |
| Operating profit before the change of operating capital | ---- | 8.75%15.97B | ---- | 17.47%14.69B | ---- | 16.51%12.5B | ---- | 32.24%10.73B | ---- | -1.29%8.12B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 12.57%62.26M | ---- | 122.57%55.31M | ---- | -565.63%-245.05M | ---- | 140.29%52.63M | ---- | -843.38%-130.63M |
| Developing property (increase)decrease | ---- | -8.49%-3.72B | ---- | -20.78%-3.43B | ---- | -61.67%-2.84B | ---- | 10.25%-1.76B | ---- | -468.13%-1.96B |
| Accounts receivable (increase)decrease | ---- | -13.43%-18.42B | ---- | -16.20%-16.24B | ---- | 16.90%-13.97B | ---- | -14.44%-16.81B | ---- | -8.30%-14.69B |
| Accounts payable increase (decrease) | ---- | 144.95%16.86B | ---- | -47.84%6.88B | ---- | 57.58%13.19B | ---- | 68.18%8.37B | ---- | -38.56%4.98B |
| Advance payment increase (decrease) | ---- | -174.82%-9.11M | ---- | 60.28%-3.32M | ---- | -658.84%-8.35M | ---- | -94.46%1.49M | ---- | 496.64%26.97M |
| prepayments (increase)decrease | ---- | 15.98%-90.87M | ---- | -151.62%-108.15M | ---- | -53.11%209.49M | ---- | 145.31%446.75M | ---- | -316.57%-986.05M |
| Special items for working capital changes | ---- | -1,332.72%-6.1B | ---- | 107.53%494.67M | ---- | -2,593.08%-6.57B | ---- | -84.44%263.41M | ---- | 132.24%1.69B |
| Cash from business operations | ---- | 94.64%4.55B | ---- | 2.98%2.34B | ---- | 75.08%2.27B | ---- | 143.93%1.3B | ---- | -35.91%-2.95B |
| Other taxs | ---- | -38.48%-2.55B | ---- | 10.74%-1.84B | ---- | -11.39%-2.06B | ---- | -17.18%-1.85B | ---- | -197.10%-1.58B |
| Special items of business | 6,636.50%123.28M | ---- | -98.91%1.83M | ---- | 64.78%167.55M | ---- | 110.47%101.68M | ---- | 80.69%-971.27M | ---- |
| Net cash from operations | 6,636.50%123.28M | 300.69%2.01B | -98.91%1.83M | 136.19%500.99M | 64.78%167.55M | 138.46%212.12M | 110.47%101.68M | 87.83%-551.49M | 80.69%-971.27M | -67.57%-4.53B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 21.65%177.67M | 9.03%309.41M | 13.43%146.04M | 17.63%283.78M | 15.68%128.75M | -16.05%241.25M | -9.70%111.3M | 3.92%287.38M | -21.70%123.26M | 10.92%276.55M |
| Dividend received - investment | 7.91%329.37M | -20.34%509.78M | -23.81%305.23M | -24.54%639.95M | -21.08%400.61M | 12.31%848.03M | 8.56%507.63M | -55.86%755.11M | 59.09%467.59M | -20.16%1.71B |
| Loan receivable (increase) decrease | -105.56%-17.52M | 281.48%226.51M | 439.88%315.29M | -138.90%-124.81M | -144.21%-92.76M | --320.84M | --209.81M | ---- | ---- | -107.97%-54.6M |
| Decrease in deposits (increase) | ---- | -106.39%-19.67M | ---- | 197.02%308.07M | ---- | -1,353.18%-317.55M | ---- | -7.04%-21.85M | ---- | 6.13%-20.41M |
| Sale of fixed assets | ---- | 38.12%72.64M | ---- | 78.56%52.59M | ---- | -39.22%29.46M | ---- | 259.71%48.46M | ---- | -8.48%13.47M |
| Purchase of fixed assets | 12.74%-318.64M | -89.55%-1.07B | -141.28%-365.16M | -55.01%-562.48M | 10.37%-151.34M | 47.14%-362.86M | 39.11%-168.86M | -25.17%-686.41M | -52.41%-277.29M | -9.07%-548.38M |
| Purchase of intangible assets | ---- | -2,800.31%-85.33M | ---- | ---2.94M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | -60.61%196.6M | --231.03M | -74.82%499.13M | ---- | 2,090.74%1.98B | --1.61B | -93.34%90.5M | ---- | --1.36B |
| Acquisition of subsidiaries | --79.35M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | --14.54M | -91.51%3.98M | ---- | -95.75%46.94M | ---- | 10,907.36%1.1B | --709.11M | --10.04M | ---- | ---- |
| Cash on investment | 110.71%109.19M | -215.89%-155.3M | -297.36%-1.02B | 117.64%134.01M | 208.39%516.53M | 81.66%-759.86M | 72.58%-476.57M | -110.51%-4.14B | -14.76%-1.74B | 56.14%-1.97B |
| Other items in the investment business | 93.42%-70.31M | 1,236.87%1.14B | -462.35%-1.07B | 96.11%-100.66M | 148.45%294.78M | -102.48%-2.59B | 23.90%-608.48M | -187.88%-1.28B | -451.19%-799.54M | 69.77%-443.65M |
| Net cash from investment operations | 120.87%303.64M | -3.14%1.14B | -232.70%-1.46B | 134.32%1.17B | -42.25%1.1B | 110.14%500.84M | 185.37%1.9B | -1,621.42%-4.94B | -61.02%-2.22B | 110.50%324.54M |
| Net cash before financing | 129.38%426.92M | 87.76%3.14B | -214.96%-1.45B | 134.88%1.67B | -36.81%1.26B | 112.99%712.96M | 162.60%2B | -30.47%-5.49B | 50.16%-3.2B | 27.39%-4.21B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 25.56%20.96B | 42.00%49.27B | -5.89%16.7B | 30.42%34.7B | 36.69%17.74B | -13.76%26.6B | 3.23%12.98B | -6.05%30.85B | -39.25%12.57B | 1.78%32.83B |
| Refund | -73.32%-20.06B | -81.35%-44.63B | -7.31%-11.57B | -15.55%-24.61B | 6.70%-10.79B | 3.79%-21.3B | 24.54%-11.56B | 21.53%-22.14B | -30.40%-15.32B | -27.26%-28.21B |
| Issuing shares | --2.8B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance of bonds | 89.59%5.5B | 181.98%9.67B | --2.9B | -16.58%3.43B | ---- | -40.50%4.11B | -43.17%2.89B | 146.66%6.91B | --5.09B | -27.72%2.8B |
| Dividends paid - financing | ---- | -21.81%-3.22B | ---- | -14.60%-2.65B | ---- | -17.54%-2.31B | ---- | -17.91%-1.96B | ---- | -16.68%-1.67B |
| Absorb investment income | ---- | -60.37%81.38M | ---- | 165.26%205.36M | ---- | -81.51%77.42M | ---- | 42.89%418.75M | ---- | 44.74%293.07M |
| Issuance expenses and redemption of securities expenses | -246.00%-3.46B | -175.62%-7.71B | ---1B | 34.82%-2.8B | ---- | -8.48%-4.29B | ---- | ---3.95B | ---- | ---- |
| Other items of the financing business | 20.20%-1.38B | -1.12%-3.64B | 0.77%-1.73B | -8.08%-3.6B | -7.71%-1.74B | -7.35%-3.33B | -19.16%-1.62B | 0.79%-3.1B | 5.51%-1.36B | -42.03%-3.13B |
| Net cash from financing operations | -17.65%4.36B | -107.68%-349.09M | 1.53%5.29B | 963.04%4.55B | 93.66%5.21B | -107.57%-527.02M | 173.87%2.69B | 141.69%6.96B | -86.92%982.45M | -72.58%2.88B |
| Effect of rate | -70.90%-159.94M | 59.86%-534.87M | 90.92%-93.59M | -30.05%-1.33B | 8.49%-1.03B | -325.85%-1.02B | -1,276.66%-1.13B | -60.10%453.67M | 149.88%95.75M | 3,252.44%1.14B |
| Net Cash | 24.67%4.78B | -55.08%2.8B | -40.74%3.84B | 3,246.69%6.22B | 38.02%6.47B | -87.39%185.94M | 311.99%4.69B | 211.22%1.47B | -301.39%-2.21B | -128.14%-1.33B |
| Begining period cash | 10.58%28.51B | 20.81%28.39B | 9.69%25.78B | -3.45%23.5B | -3.45%23.5B | 8.60%24.34B | 8.60%24.34B | -0.83%22.41B | -0.83%22.41B | 26.09%22.6B |
| Cash at the end | 12.22%33.13B | 7.96%30.65B | 2.00%29.52B | 20.81%28.39B | 3.73%28.94B | -3.45%23.5B | 37.50%27.9B | 8.60%24.34B | -13.67%20.29B | -0.83%22.41B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | HKD | CNY | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.